L-765,314

L-765,314
(IUPAC) ime
	benzil (2S)-4-(4-amino-6,7-dimetoksihinazolin-2-il)-2-(tert-butilkarbamoil)piperazin-1-karboksilat
Klinički podaci
Identifikatori
ATC kod	nije dodeljen
PubChem	6603904
ChEMBL	CHEMBL19476
Hemijski podaci
Formula	C27H34N6O5
Mol. masa	522,595 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C27H34N6O5/c1-27(2,3)31-24(34)20-15-32(11-12-33(20)26(35)38-16-17-9-7-6-8-10-17)25-29-19-14-22(37-5)21(36-4)13-18(19)23(28)30-25/h6-10,13-14,20H,11-12,15-16H2,1-5H3,(H,31,34)(H2,28,29,30) ; Key: CGWOIDCAGBKOQL-UHFFFAOYSA-N
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

L-765,314 je lek koji deluje kao potentan i selektivan antagonist za alfa-1 adrenergički receptor α_1B.^[4] On se uglavnom koristi za istraživanje uloge α_1B receptora u regulaciji krvnog pritiska,^[5]^[6] mada se smatra da α_1B receptor isto tako ima važnu ulogu u mozgu.^[7]

Reference[uredi - уреди | uredi kôd]

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit
↑ Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG (April 1998). „4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist ”. Journal of Medicinal Chemistry 41 (8): 1205–8. DOI:10.1021/jm980053f. PMID 9548811.
↑ Yang XP, Chiba S (August 2002). „Effects of L-765,314, a selective and potent alpha 1B-adrenoceptor antagonist, on periarterial nerve electrical stimulation-induced double-peaked constrictor responses in isolated dog splenic arteries”. Japanese Journal of Pharmacology 89 (4): 429–32. DOI:10.1254/jjp.89.429. PMID 12233824.
↑ Görnemann T, Villalón CM, Centurión D, Pertz HH (June 2009). „Phenylephrine contracts porcine pulmonary veins via alpha(1B)-, alpha(1D)-, and alpha(2)-adrenoceptors”. European Journal of Pharmacology 613 (1–3): 86–92. DOI:10.1016/j.ejphar.2009.04.011. PMID 19376108.
↑ Hillman KL, Doze VA, Porter JE (June 2007). „Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus”. The Journal of Pharmacology and Experimental Therapeutics 321 (3): 1062–8. DOI:10.1124/jpet.106.119297. PMID 17337632.

Spoljašnje veze[uredi - уреди | uredi kôd]

	Portal Medicina
	Portal Hemija

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. http://www.sciencedirect.com/science/article/pii/S1359644610007737. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594. edit

[pmid9548811-4] Patane MA, Scott AL, Broten TP, Chang RS, Ransom RW, DiSalvo J, Forray C, Bock MG (April 1998). „4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist ”. Journal of Medicinal Chemistry 41 (8): 1205–8. DOI:10.1021/jm980053f. PMID 9548811.

[pmid12233824-5] Yang XP, Chiba S (August 2002). „Effects of L-765,314, a selective and potent alpha 1B-adrenoceptor antagonist, on periarterial nerve electrical stimulation-induced double-peaked constrictor responses in isolated dog splenic arteries”. Japanese Journal of Pharmacology 89 (4): 429–32. DOI:10.1254/jjp.89.429. PMID 12233824.

[pmid19376108-6] Görnemann T, Villalón CM, Centurión D, Pertz HH (June 2009). „Phenylephrine contracts porcine pulmonary veins via alpha(1B)-, alpha(1D)-, and alpha(2)-adrenoceptors”. European Journal of Pharmacology 613 (1–3): 86–92. DOI:10.1016/j.ejphar.2009.04.011. PMID 19376108.

[pmid17337632-7] Hillman KL, Doze VA, Porter JE (June 2007). „Alpha1A-adrenergic receptors are functionally expressed by a subpopulation of cornu ammonis 1 interneurons in rat hippocampus”. The Journal of Pharmacology and Experimental Therapeutics 321 (3): 1062–8. DOI:10.1124/jpet.106.119297. PMID 17337632.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

L-765,314

Reference[uredi - уреди | uredi kôd]

Spoljašnje veze[uredi - уреди | uredi kôd]

Navigacijski meni

Traži-Тражи